Strong hands pick up the cheap shares due to unchanged AVXL fundamentals. I hope to gather a few shares myself tomorrow or Friday. I would be surprised if shorts hold it over the Labor Day Holiday.
With so many retailers involved here, tree shaking is easy for the MM to get some shares. Hits a few stops which only weak minded rookies use drops the price. Not worried, as soon as it gets too low to ignore the buyers will be back in full force.
Too many good bargains in biotech with the sector sell off. But to me this failed deal tells me ARIA is worth at the minimum, about $10+. Baxalta not willing to make it work is just part of the game, they could come back or simply look at other biotect oncology bargains, like EXEL, ARRY. Perhaps other forces at work here didn't want the deal anyway. Bottom line ARIA is now very undervalued.
"As well as disagreements over price, Baxalta also backed off after receiving negative feedback about the prospect of a takeover of Ariad from some of its own investors, one of the people said."
So by posting this are you thinking 2-73 could be a treatment for Prion diseases....interesting thought, that's thinking out of the box. Nice. But a difficult disease to study. No one would want to be around any patients with a Prion disease. Even Pathologist don't want to do autopsy's on bodies of suspected "infections".
It's a protein that can cause deadly diseases like Creutzfeldt-Jakob Disease. it is not a living organism, but you can consider it "Viral-like".
I am seriously considering putting you on IGNORE if you put up one more post like this. You are welcome to enjoy your "Freedom of Speech", but remember it's not "Freedom of Speech without Consequences".
Well a lot of swing traders and retail longs, but most mutual funds will not buy any stock less than $10. Still considered speculative.
I can't remember but wasn't this old issue discussed in the last Q and A session of the last Qrpt?
When you see the shorts screaming garbage(Phase 3) ...they are very close to COVERING(Phase 4).
Never waste your time with these humps, just place them on IGNORE and move on.
Now even if there are no studies to back up the use of 2-73 for Mild Traumatic Brain Injuries or Vascular Dementia, 2-73 might get some Off-Label use esp with a clean side effect profile there will be little risk in trying 2-73 for MTBI and Vascular Dementia.